Baltimore, Drug Manufacturer Agree To $45 Million Deal To End Opioid Litigation
BALTIMORE — Allergan Finance LLC will pay $45 million to Baltimore in a lump sum payment within 30 days to end litigation stemming from claims that the drug manufacturer contributed to...To view the full article, register now.
Already a subscriber? Click here to view full article